NAVB stock forecast
Our latest prediction for Navidea Biopharmaceuticals, Inc.'s stock price was made on the June 5, 2019 when the stock price was at 1.23$.
In the short term (2weeks), NAVB's stock price should outperform the market by 6.14%. During that period the price should oscillate between -12.05% and +27.75%.
In the medium term (3months), NAVB's stock price should outperform the market by 14.01%. During that period the price should oscillate between -24.15% and +66.56%.Get email alerts
About Navidea Biopharmaceuticals, Inc.
Navidea Biopharmaceuticals, Inc. engages in the development and commercialization of precision immunodiagnostic agents and immunotherapeutics. It operates through the following segments: Diagnostics, Therapeutics, and Corporate. The company was founded in 1983 and is headquartered in Dublin, OH.
At the moment the company generates 1M USD in revenues.
On its last earning announcement, the company reported a loss of -0.84$ per share.
The book value per share is 0.01$
Three months stock forecastJune 5, 2019
|Revenue USD||Gross Margin||Operating Income||Operating Margin||Net Income||Earnings Per Share||Dividends||Payout Ratio||Shares||Book Value Per Share||Operating Cash Flow||Cap Spending||Free Cash Flow|